Yes. OHC will help you with your medical-related finances. All of our patients have access to one of our expert Financial Navigators. They will help you understand and deal with the financial complexities of your cancer care. You can go to your... Read More

OHC Expands Service Area

OHC

OHC is expanding. Soon, we will be serving our patients in the Mt. Airy, Rapid Run, and Western Hills areas. “OHC West” will operate on the first two floors of a five-story medical office building adjacent to the new Mercy Health-West Hospital in... Read More

Cincinnati Magazine’s 2013 Top Doctors list includes 26 OHC physicians — more than half of its physicians. The magazine surveyed more than 5,000 medical doctors in our region to determine whom they would turn to if they, a family member, or a... Read More

Not hungry? Maybe you can drink your nutrition today. But don’t healthy drinks taste like chalk? Not if you know what to make and how to make it. Here’s a great recipe for a banana milkshake you’re going to love…and it’s... Read More

Chemotherapy can cause your appetite to change. You may lose your appetite because of nausea (feeling like you’re going to throw up), mouth and throat problems that make it painful to eat, or drugs that cause you to lose your taste for food.... Read More

After a patient successfully completes his or her treatment for cancer, elation is often followed by the fear of recurrence. That is why we encourage all physicians involved in those patients’ care to speak with them about the need for consistent... Read More

OHC’s gynecologic oncology surgeons, Marcia Bowling, M.D. and Nancy Simon, M.D. are regional leaders in the use of the da Vinci Surgery System on women with gynecologic cancers. The da Vinci System allows for a high degree of precision, and... Read More

OHC participated in the clinical trial titled, “A Single-Arm, Open-Label, Expanded Access Study of RO5185426 in Patients with Metastatic Melanoma.” The purpose of this clinical trial was to allow access to this study drug to patients in which... Read More

OHC participated in the clinical trial titled, “A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based... Read More